Tesla with sales decline + SAP maintains cloud growth rate and confirms outlook + Danaher's statements also drive Sartorius, Stedim and Evotec
Tesla $TSLA (-3.21%)with decline in sales
- Tesla recorded a nine percent drop in sales to 19.3 billion dollars and a 71 percent drop in profits to 409 million dollars in the past quarter.
- Analyst Dan Ives from Wedbush Securities estimates that Elon Musk's political activities could permanently reduce demand for Tesla by 15 to 20 percent.
- In its current quarterly report, Tesla refrains from its usual forecast of a return to growth.
- For the first time in its Q1 earnings report, Tesla does not mention when the company intends to return to growth.
- Tesla Inc. misses analysts' estimates of USD 0.42 with earnings per share of USD 0.27 in the first quarter. Revenue of USD 19.34 billion below expectations of USD 21.4 billion.
- Tech billionaire Elon Musk initiates withdrawal from Washington.
- From May, he will spend "considerably" less time in the government apparatus as President Donald Trump's cost-cutter, said the Tesla boss.
- Instead, he will focus more on the interests of the electric car manufacturer.
SAP $SAP (+0.97%)maintains cloud growth rate and confirms outlook
- SAP maintained its cloud growth in the first quarter and significantly increased its operating profit.
- The Walldorf-based software group confirmed its outlook for the current year.
- According to the DAX-listed company, the environment is characterized by high dynamics and uncertainty and further developments are difficult to predict.
- SAP is targeting currency-adjusted cloud growth of 26 to 28 percent to 21.6 to 21.9 billion euros this year.
- Cloud and software combined are expected to grow by 11 to 13 percent to 33.1 to 33.6 billion euros.
- The non-IFRS operating result is expected to reach EUR 10.3 to 10.6 billion after EUR 8.15 billion in 2024.
- In the first quarter, cloud revenue rose by 26% in constant currency to just under EUR 5 billion.
- Analysts had expected a consensus of EUR 5.06 billion from Visible Alpha.
- Currency-adjusted growth had already amounted to 26% in the fourth quarter.
- Non-IFRS operating profit rose by 58% to EUR 2.46 billion.
- The Current Cloud Backlog (CCB), which quantifies secured orders over the course of a year, rose by 29% to EUR 18.2 billion after adjusting for currency effects.
- The initial reaction of the share in after-hours trading in Germany was positive. They rose by more than 5 percent to 231 euros at the broker Lang & Schwarz.
- The SAP share had closed 3.32 percent lower at 218.50 euros on XETRA on Tuesday.
- SAP ADRs traded on the NYSE rose 6.48 percent to 268.75 US dollars in after-hours trading.
Danaher's $DHR (-0.43%)statements also drove Sartorius$SRT (+0%)Stedim $DIM (-0.47%)and Evotec $EVT (-1.4%)on
- The quarterly figures of the US pharmaceutical equipment manufacturer Danaher boosted the shares of Sartorius and its subsidiary Sartorius Stedim Biotech on Tuesday.
- The shares of pharmaceutical contract researcher Evotec also benefited.
- The reason for this was not only the better than expected results in the first quarter and the confirmation of the Group's annual targets.
- The fact that Danaher performed particularly well in the bioprocess technology segment, which is also an important pillar of the Göttingen-based Sartorius Group, probably put investors in a good mood.
- In addition, Danaher spoke of continued robust spending on research and development in the pharmaceutical sector.
- In the afternoon, the Sartorius preference share rose 5.9 percent to 221.30 euros at the top of the leading German Dax index and is thus back at its highest level since the end of March.
- The 21-day line, which signals the short-term trend, had already been overcome on Wednesday.
- The 50-day line as an indicator of the medium-term trend at just under EUR 226 and the long-term 200-day line at just over EUR 234 are now the next decisive resistances.
- The shares of French company Stedim Biotech recently rose by 3.9% to EUR 194.35 in Paris.
- In the MDax, the mid-cap index below the Dax, Evotec shares rose by 6.7 percent to 6.82 euros, while in the USA Danaher shares rose by 5.0 percent to 194.09 US dollars.
- Analyst Rachel Vatnsdal from the US bank JPMorgan spoke of Danaher "comfortably exceeding expectations" and "remarkable strength" in the bioprocessing sector.
- The bioprocessing division was the leader in the first quarter, she wrote.
- Compared to the previous quarter, orders there had increased significantly, while the company had also noted that it had not noticed any pull-forward effects in view of impending tariffs.
- According to stock market analysts, this should also have a positive effect on the industry as a whole.
- Like Sartorius, Danaher is broadly positioned in the healthcare sector with businesses in biotechnology and diagnostics.
Wednesday: Stock market dates, economic data, quarterly figures
- ex-dividend of individual stocks
- Lenzing EUR 3.00
- Heineken EUR 1.17
- Proximus EUR 0.10
- Adecco Group 1.00 CHF
- Quarterly figures / company dates USA / Asia
- 12:30 AT&T | GE Vernova | Boston Scientific quarterly figures
- 13:00 Philip Morris quarterly figures
- 13:30 Boeing quarterly figures
- 15:30 Goldman Sachs AGM
- 16:00 Cigna AGM
- 22:00 IBM | Texas Instruments | Lam Research
- 22:00 ResMed | Whirlpool quarterly figures
- No time specified: BYD quarterly figures
- Quarterly figures / Company dates Europe
- 07:30 Danone | Essilor-Luxottica 1Q sales
- 07:30 Volvo AB | Akzo Nobel quarterly figures
- 08:00 Reckitt Benckiser Trading Update 1Q
- 09:00 Just Eat Takeaway Trading Update 1Q
- 10:00 ASML | Sulzer Holding AGM
- 17:45 Kering quarterly figures
- Economic data
09:15 FR: Purchasing Managers' Index/PMI non-manufacturing | Purchasing Managers' Index/PMI manufacturing (1st release)
09:30 DE: Purchasing Managers' Index/PMI non-manufacturing (1st release) April PROGNOSE: 50.3 PREVIOUS: 50.9 Total Purchasing Managers' Index (1st release) PROGNOSE: 51.0 PREVIOUS: 51.3
09:30 DE: Purchasing Managers' Index/PMI manufacturing (1st release) April FORECAST: 47.6 PREVIOUS: 48.3
10:00 EU: Purchasing Managers' Index/PMI non-manufacturing Eurozone (1st release) April FORECAST: 50.5 PREVIOUS: 51.0
10:00 EU: Purchasing Managers' Index/PMI Manufacturing Eurozone (1st release) April FORECAST: 47.5 previously: 48.6 Total Purchasing Managers' Index (1st release) FORECAST: 50.4 previously: 50.9
10:30 UK: Purchasing Managers' Index/PMI non-manufacturing (1st release) Apri PROGNOSE: 51.6 previous: 52.5 | Purchasing Managers' Index/PMI manufacturing (1st release) April PROGNOSE: 44.2 previous: 44.9
11:00 EU: Trade Balance February
15:00 US: IMF, Fiscal Monitor
15:30 US: Fed St. Louis President Musalem and Fed Governor Waller, participate in Fed Listens Event
15:45 US: Purchasing Managers' Index/PMI Services (1st release) April Forecast: 52.8 Previous: 54.4 | Purchasing Managers' Index/PMI Manufacturing (1st release) April Forecast: 49.5 Previous: 50.2
16:00 US: New Home Sales March FORECAST: +1.3% yoy previous: +1.8% yoy
16:30 US: Crude oil inventories data (week) from the Energy Information Administration (EIA) previous week
18:00 US: Governing Council member Knot, speech at Peterson Institute conference
20:00 US: Fed, Beige Book
21:15 US: ECB Chief Economist Lane, participation in panel at IMF Spring Meetings
21:45 US: ECB Director Cipollone, participation in panel at IMF Spring Meetings
No time specified: CN: Auto Shanghai 2025 exhibition in Shanghai
